JP2002238494A - Method for producing lactobacillus fermented liquor, and food using the same as raw material - Google Patents

Method for producing lactobacillus fermented liquor, and food using the same as raw material

Info

Publication number
JP2002238494A
JP2002238494A JP2001190333A JP2001190333A JP2002238494A JP 2002238494 A JP2002238494 A JP 2002238494A JP 2001190333 A JP2001190333 A JP 2001190333A JP 2001190333 A JP2001190333 A JP 2001190333A JP 2002238494 A JP2002238494 A JP 2002238494A
Authority
JP
Japan
Prior art keywords
yeast
lactic acid
acid bacteria
food
fermented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001190333A
Other languages
Japanese (ja)
Other versions
JP4336930B2 (en
Inventor
Atsushi Yamanishi
敦之 山西
Katsuhiko Sato
雄彦 佐藤
Junko Fujimoto
純子 藤本
Kiyoko Takai
許子 高井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP2001190333A priority Critical patent/JP4336930B2/en
Publication of JP2002238494A publication Critical patent/JP2002238494A/en
Application granted granted Critical
Publication of JP4336930B2 publication Critical patent/JP4336930B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide food and medicine such as lactic acid bacteria beverage, where unpleasant taste, smell or bitterness of yeast is ameliorated and reduced. SOLUTION: The objective method for producing lactobacillus fermented liquor is characterized by fermenting dry yeast with lactobacillus, and the food and medicine using the fermented liquor as a raw material are provided.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、新規な乳酸菌発酵
液の製造方法及び該発酵液を原料とする食品・医薬に関
する。
TECHNICAL FIELD The present invention relates to a method for producing a novel fermented lactic acid bacterium and a food / medicine using the fermented liquor as a raw material.

【0002】[0002]

【従来の技術】酵母は古くから発酵食品の製造過程で利
用されており、パンやビールはもちろん、日本人の食卓
には欠かせない味噌,醤油,日本酒など、酵母を利用し
た醸造産業は近代以前の産業界では重要な位置を占めて
いた。
2. Description of the Related Art Yeast has been used in the manufacturing process of fermented foods for a long time. The brewing industry using yeast, such as bread and beer, as well as miso, soy sauce, and sake, which are indispensable for Japanese dining tables, is modern. Earlier, it occupied an important position in industry.

【0003】近年、酵母細胞内の成分の生化学的解明が
進むにつれ、酵母のもつ栄養学的特性,薬理効果を期待
して積極的に利用しようとする動きが盛んになってき
た。酵母のもつ栄養学的特性は、(1)良質な高蛋白、必
須アミノ酸をバランスよく含む、(2)豊富なビタミン,
ミネラル含量、(3)核酸、多糖類に富む、などがあげら
れ、以上の効用から総合ビタミン補給剤,胃腸薬剤,飼
料の栄養強化剤として利用されている。
[0003] In recent years, as the biochemical elucidation of the components in yeast cells has progressed, active efforts have been made to actively use yeast in view of the nutritional characteristics and pharmacological effects of yeast. The nutritional properties of yeast include (1) a good balance of high-quality, high-protein, essential amino acids, (2) abundant vitamins,
It is rich in mineral content, (3) rich in nucleic acids and polysaccharides, etc., and is used as a general vitamin supplement, gastrointestinal drug, and feed fortifier because of the above effects.

【0004】しかし、酵母を栄養強化の目的として加工
食品に配合しようとした場合、酵母独特の好ましくない
臭いや苦み,呈味があるため、その用途や使用量等に制
約を受けることが多い。即ち、錠剤型とすると、酵母の
臭い、苦みなどをあまり感じなくなるが、所望の効果を
得るためには多量のタブレットを摂取する必要があり、
毎日継続して摂取するのが困難である。一方、飲料の形
態とすると、所要量(有効量)の摂取は容易であるが、
酵母の臭い、苦みなどのため非常に飲みにくいものとな
る。
[0004] However, when yeast is to be incorporated into processed foods for the purpose of fortification, there are often restrictions on the use and amount of the yeast, because of the undesirable odor, bitterness, and taste unique to yeast. That is, if the tablet type, the smell of yeast, bitterness, etc. will not be felt much, but in order to obtain the desired effect, it is necessary to ingest a large amount of tablets,
It is difficult to take continuously every day. On the other hand, if it is in the form of a beverage, it is easy to ingest the required amount (effective amount),
It is very difficult to drink due to the smell and bitterness of yeast.

【0005】そこで、酵母のもつ不快臭のマスキング方
法として、従来化学物質や香料などの添加,加熱処理,
酵素処理等が提案,実施されている。しかしこれらの方
法は、十分な効果が得られない、操作が煩雑で経済的で
ない、衛生上問題がある等の欠点があり、酵母はその高
い栄養学的価値にもかかわらず、健康食品素材としては
十分活用されていないのが現状である。
[0005] Therefore, as a method of masking the unpleasant odor of yeast, conventionally, addition of chemical substances and flavors, heat treatment,
Enzyme treatment has been proposed and implemented. However, these methods have drawbacks such as insufficient effect, complicated operation, not economical, and hygienic problems.Yeast is a health food material despite its high nutritional value. Is not fully utilized at present.

【0006】一方、生酵母を酵母細胞壁溶解酵素で処理
した後、乳酸発酵させる技術が提案されているが、この
場合、酵素処理中の微生物汚染の問題や、酵素処理によ
って酵母細胞中に含まれるタンパク、ペプチド等が完全
に溶出し、またその一部がアミノ酸まで分解されるの
で、香味の点で好ましくない。
On the other hand, a technique has been proposed in which live yeast is treated with a yeast cell wall lysing enzyme, followed by lactic acid fermentation. In this case, however, there is a problem of microbial contamination during the enzyme treatment, and the yeast is contained in yeast cells by the enzyme treatment. Proteins, peptides and the like are completely eluted and some of them are decomposed into amino acids, which is not preferable in terms of flavor.

【0007】また、穀類,野菜,畜肉等を酵母菌,乳酸
菌,麹菌等により発酵し、素材の不快味および不快臭を
改良,低減する方法はこれまで種々提案されてきたが、
酵母そのものの不快味,不快臭,苦みを乳酸菌発酵によ
り改良,低減するという発想はこれまでにはなかった。
Various methods have been proposed to improve or reduce the unpleasant taste and unpleasant odor of raw materials by fermenting cereals, vegetables, livestock meat and the like with yeast, lactic acid bacteria, koji mold and the like.
The idea of improving and reducing the unpleasant taste, unpleasant odor, and bitterness of the yeast itself by lactic acid bacteria fermentation has not been developed so far.

【0008】[0008]

【発明が解決しようとする課題】本発明は、上記したよ
うな欠点のない酵母の乳酸菌発酵液の製造方法及び該発
酵液を原料とする食品や医薬を提供することを目的とす
る。
SUMMARY OF THE INVENTION An object of the present invention is to provide a method for producing a lactic acid bacterium fermented liquid of yeast which does not have the above-mentioned disadvantages, and a food or a medicine using the fermented liquid as a raw material.

【0009】[0009]

【課題を解決するための手段】このような事情を鑑み、
本発明者は栄養学的価値の高い酵母を手軽においしく摂
取できる、望ましい加工食品を提供するために鋭意検討
した結果、乾燥酵母を乳酸菌で発酵させることにより、
酵母本来のもつ独特の不快臭,苦み,呈味がマスキング
された嗜好性の高い飲料が得られることを見出した。
In view of such circumstances,
The present inventor can easily ingest high nutritional value yeast easily and deliciously, as a result of intensive studies to provide a desirable processed food, by fermenting dry yeast with lactic acid bacteria,
It has been found that a highly palatable beverage can be obtained in which the unique unpleasant odor, bitterness and taste of yeast are masked.

【0010】即ち、本発明は下記の各項に示された発明
に関する。 項1 乾燥酵母を乳酸菌で発酵することを特徴とする、
乳酸菌発酵液の製造方法。 項2 発酵を、好気的条件で行うことを特徴とする項1
記載の製造方法。 項3 発酵を、麦芽エキスの存在下で行うことを特徴す
る項1または2記載の製造方法。 項4 乳酸菌としてLactobacillus rhamnosus 及びLact
obacillus plantarumからなる群より選ばれる少なくと
も1種を用いることを特徴とする項1〜3のいずれかに
記載の製造方法。 項5 乾燥酵母が、乾燥ビール酵母であることを特徴と
する項1〜4のいずれかに記載の製造方法。 項6 乾燥酵母を乳酸菌で発酵して得ることができる乳
酸菌発酵液を原料とする食品。 項7 整腸作用を有する、項6に記載の食品。 項8 乾燥酵母を乳酸菌で発酵して得ることができる乳
酸菌発酵液を原料として含む便秘薬。 項9 乾燥酵母を乳酸菌で発酵して得ることができる乳
酸菌発酵液を原料として含む整腸薬。
That is, the present invention relates to the inventions described in the following items. Item 1 characterized by fermenting dry yeast with lactic acid bacteria,
A method for producing a fermented lactic acid bacterium. Item 2 Fermentation is carried out under aerobic conditions. Item 1
The manufacturing method as described. Item 3. The method according to Item 1 or 2, wherein the fermentation is performed in the presence of a malt extract. Item 4 Lactobacillus rhamnosus and Lact as lactic acid bacteria
Item 4. The method according to any one of Items 1 to 3, wherein at least one selected from the group consisting of obacillus plantarum is used. Item 5. The method according to any one of Items 1 to 4, wherein the dried yeast is a dried brewer's yeast. Item 6. A food product obtained from a fermented lactic acid bacterium obtained by fermenting dry yeast with lactic acid bacteria. Item 7 The food according to Item 6, which has an intestinal action. Item 8 A constipation drug containing, as a raw material, a lactic acid bacteria fermented solution that can be obtained by fermenting dry yeast with lactic acid bacteria. Item 9: An intestinal medicine containing, as a raw material, a lactic acid bacteria fermented solution that can be obtained by fermenting dry yeast with lactic acid bacteria.

【0011】[0011]

【発明の実施の形態】本発明においては、乾燥酵母を用
いる。乾燥酵母は、生酵母をドラム乾燥,噴霧乾燥,通
気乾燥などの方法により乾燥,粉末化したものであり、
水分が10%以下のものである。本発明では、活性乾燥
酵母を用いてもよく、不活性乾燥酵母を用いてもよい。
DETAILED DESCRIPTION OF THE INVENTION In the present invention, dried yeast is used. Dried yeast is obtained by drying and pulverizing live yeast by methods such as drum drying, spray drying, and through-flow drying.
The water content is 10% or less. In the present invention, active dry yeast may be used, or inactive dry yeast may be used.

【0012】通常商業的に入手可能な酵母原料として
は、生酵母,酵母エキス,乾燥酵母等があるが、本発明
において乾燥酵母を用いる理由は以下の通りである。
[0012] Commercially available yeast raw materials include live yeast, yeast extract, and dried yeast. The reasons for using dried yeast in the present invention are as follows.

【0013】生酵母にはマンナン,グルカン,蛋白質,
脂肪等からなる極めて強固な細胞壁が存在しているため
に消化性が悪く、菌体内に含まれる豊富な栄養成分の利
用率が低いという欠点がある。酵母エキスは、生酵母を
自己消化もしくは酵素分解後水溶成分を抽出したエキス
であり、酵母由来の蛋白質が酵素分解等によりペプチ
ド,アミノ酸まで分解されており、呈味が強すぎ配合量
が制限されるという難点がある。一方、乾燥酵母は、そ
の乾燥工程において強固な細胞壁の構造がルーズにな
り、細胞質の透過性が増大しているので消化吸収性もよ
く、呈味も酵母エキスほど強くない。かかる理由によ
り、本発明において乾燥酵母を原料として用いる。
[0013] Raw yeast includes mannan, glucan, protein,
Due to the existence of extremely strong cell walls composed of fat and the like, there is a drawback that digestibility is poor and the utilization rate of abundant nutrients contained in the cells is low. The yeast extract is an extract obtained by extracting water-soluble components after autolyzing or enzymatically decomposing live yeast. The yeast-derived protein is decomposed into peptides and amino acids by enzymatic decomposition and the like, and the taste is too strong to limit the amount of compounding. Is difficult. On the other hand, the dried yeast has a strong cell wall structure loose in the drying step, and has an increased cytoplasmic permeability, so that it has good digestibility and absorption, and its taste is not as strong as yeast extract. For this reason, dry yeast is used as a raw material in the present invention.

【0014】乾燥酵母の原料としてはビール酵母、パン
酵母、トルラ酵母、石油酵母、清酒酵母などが好適であ
るが、とりわけビールの醸造の際に副産物として得られ
るビール酵母は安価かつ安定的に入手できるのでより好
ましい。
As a raw material of the dried yeast, brewer's yeast, baker's yeast, tolula yeast, petroleum yeast, sake yeast, and the like are suitable, and in particular, brewer's yeast obtained as a by-product during brewing of beer is cheaply and stably available. It is more preferable because it is possible.

【0015】また、本発明では、乳酸菌であれば特に限
定されず用いることができ、通性ヘテロ発酵タイプ、絶
対ホモ発酵タイプ、絶対ヘテロ発酵タイプのいずれであ
ってもよい。これらの中でも、乾燥酵母の発酵性の点か
らラクトバチルス属に属する菌が好ましく、ラクトバチ
ルス属の通性ヘテロ発酵タイプの乳酸菌がより好まし
い。さらには、乾燥酵母の香味のマスキング効果からみ
て、ラクトバチルス・プランタラム,ラクトバチルス・
ラムノサス,ラクトバチルス・カゼイ,ラクトバチルス
・アリメンタリウス,ラクトバチルス・コリニフォルミ
スなどが好適で、特にラクトバチルス・プランタラム,
ラクトバチルス・ラムノサスが好ましい。これらは単
独、又は任意の組み合わせで用いることができる。
In the present invention, any lactic acid bacteria can be used without particular limitation, and may be any of a facultative hetero-fermentation type, an absolute homo-fermentation type, and an absolute hetero-fermentation type. Among these, bacteria belonging to the genus Lactobacillus are preferred from the viewpoint of fermentability of the dried yeast, and lactobacilli of the facultative heterofermentative type of the genus Lactobacillus are more preferred. Furthermore, in view of the masking effect of the flavor of dried yeast, Lactobacillus plantarum, Lactobacillus
Rhamnosus, Lactobacillus casei, Lactobacillus alimentarius, Lactobacillus coriniformis and the like are preferred, and in particular Lactobacillus plantarum,
Lactobacillus rhamnosus is preferred. These can be used alone or in any combination.

【0016】ストレプトコッカス・ラクチス,エンテロ
コッカス・フェシウム等の乳酸球菌も、本発明方法にお
いて乳酸菌として用いることができるが、これら球菌
は、ラクトバチルス属に属する乳酸菌と組み合わせて乾
燥酵母の発酵に用いることが好ましい。
Lactococci such as Streptococcus lactis and Enterococcus faecium can also be used as lactic acid bacteria in the method of the present invention. However, these cocci are preferably used in combination with lactic acid bacteria belonging to the genus Lactobacillus for fermentation of dry yeast. .

【0017】本発明方法においては、1〜30重量%程
度、好ましくは5〜20重量%程度の乾燥酵母の懸濁液
を調製後、乳酸菌が資化できる糖質源を、添加後の濃度
が0.5〜20重量%程度、好ましくは1〜10重量%
程度となるように添加することが望ましい。糖質源とし
ては、乳酸菌が資化できるものであれば特に限定される
ものではないが、例えば、グルコース、キシロース、フ
ラクトース、サッカロース、マルトース、トレハロー
ス、パラチノース、ラクトース、ガラクトース、ガラク
トオリゴ糖、フラクトオリゴ糖、大豆オリゴ糖、マルト
オリゴ糖、イソマルトオリゴ糖、キシロオリゴ糖やこれ
ら糖を水添した糖アルコール、麦芽エキス等が挙げられ
る。これらの中でも、乾燥酵母の香味のマスキング効果
からみて麦芽エキスが最も好ましい。ここで、麦芽エキ
スは、麦芽をビール醸造における仕込み作業とほぼ同様
な方法で糖化させ、糖化液を濾過後、濃縮したもの、ま
たはさらに乾燥粉末化しものであり、食品の分野で通常
用いられているものを利用することができる。これら糖
質源は、単独、もしくは組み合わせて添加してよい。
In the method of the present invention, after preparing a suspension of dried yeast of about 1 to 30% by weight, preferably about 5 to 20% by weight, a saccharide source that can be assimilated by lactic acid bacteria is added to the suspension. About 0.5 to 20% by weight, preferably 1 to 10% by weight
It is desirable to add to such an extent. The carbohydrate source is not particularly limited as long as the lactic acid bacteria can assimilate, for example, glucose, xylose, fructose, saccharose, maltose, trehalose, palatinose, lactose, galactose, galactooligosaccharide, fructooligosaccharide, Examples include soybean oligosaccharides, maltooligosaccharides, isomaltooligosaccharides, xylo-oligosaccharides, sugar alcohols obtained by hydrogenating these sugars, and malt extract. Among these, malt extract is most preferable in view of the masking effect of the flavor of the dried yeast. Here, the malt extract is obtained by saccharifying malt by a method substantially similar to the brewing operation in beer brewing, filtering the saccharified solution, and then concentrating the powder, or further drying the powder, and is commonly used in the field of food. Can be used. These carbohydrate sources may be added alone or in combination.

【0018】また、乾燥酵母の懸濁液の調製に際して
は、栄養強化もしくは香味改善を目的として、乾燥酵母
の一部に代えて、獣乳、還元脱脂乳、大豆粉末、大豆分
離蛋白、豆乳、ホエイ;野菜や果物の磨砕物、搾汁、搾
汁濃縮物等の1種又は2種以上を、乳酸菌による発酵を
阻害しない範囲で用いることができる。
In preparing the suspension of dried yeast, animal milk, reduced skim milk, soybean powder, soybean separated protein, soymilk, Whey: One or more of grinds, squeezed juices, and squeezed juice concentrates of vegetables and fruits can be used in a range that does not inhibit fermentation by lactic acid bacteria.

【0019】上記のように調製された培地は、発酵に先
立ち90℃、5分程度の加熱殺菌を行うことが望まし
い。
The medium prepared as described above is desirably subjected to heat sterilization at 90 ° C. for about 5 minutes prior to fermentation.

【0020】発酵は、例えば、スターターを乾燥酵母懸
濁液に対し0.5〜2重量%程度接種し、定法に従って
25〜42℃程度、好ましくは30〜38℃程度で行う
ことができる。スターターは、発酵に用いる乳酸菌を、
酵母エキス、ペプトン等を添加した10〜15%還元脱
脂乳等の公知の培地を用いて定法に従って培養して調製
することができる。
The fermentation can be carried out, for example, at about 25 to 42 ° C., preferably about 30 to 38 ° C., according to a standard method, by inoculating a starter with about 0.5 to 2% by weight of the dried yeast suspension. The starter uses lactic acid bacteria used for fermentation,
It can be prepared by culturing according to a standard method using a known medium such as 10-15% reduced skim milk to which yeast extract, peptone and the like are added.

【0021】乳酸菌は通性嫌気性菌であり、通常の乳酸
菌発酵液製造過程は嫌気条件である静置発酵で行われ
る。本発明の方法においても、嫌気条件である静置発酵
において、乾燥酵母のマスキング効果が得られる。しか
しながら、本発明者は発酵中に発酵液をプロペラ攪拌器
等で攪拌するなど好気条件で発酵することにより、静置
発酵に比べて一層乾燥酵母の不快臭のマスキング効果が
増強されることを見出した。従って、本発明の方法にお
いて、乳酸菌を用いた発酵工程は、好気的に行うことが
好ましい。
Lactic acid bacteria are facultative anaerobic bacteria, and the usual lactic acid bacteria fermentation solution production process is performed by static fermentation under anaerobic conditions. Also in the method of the present invention, a masking effect of dry yeast can be obtained in stationary fermentation under anaerobic conditions. However, the present inventor has found that by performing fermentation under aerobic conditions such as stirring the fermented solution with a propeller stirrer or the like during fermentation, the masking effect of the unpleasant odor of the dried yeast is further enhanced as compared with static fermentation. I found it. Therefore, in the method of the present invention, the fermentation step using lactic acid bacteria is preferably performed aerobically.

【0022】発酵時間は乾燥酵母の濃度、その他配合成
分により適宜設定できるが、通常、8〜48時間程度
で、生成する乳酸量を目安に、所望の最終製品に適した
発酵液となるように、発酵の終点を適宜定めればよい。
The fermentation time can be appropriately set depending on the concentration of the dried yeast and other components. Usually, the fermentation time is about 8 to 48 hours so that a fermentation liquid suitable for a desired final product can be obtained based on the amount of lactic acid produced. The end point of the fermentation may be appropriately determined.

【0023】かくして得られた乳酸菌発酵液には、酵母
の味や酵母の臭みがマスキングされ、また、ビール酵母
に含まれていたタンパクがアミノ酸まで分解されないの
でアミノ酸の味があまりなく、香味の点で優れており、
食品用の原料として好適である。
The fermented lactic acid bacterium thus obtained is masked for the taste and odor of yeast, and the protein contained in brewer's yeast is not decomposed into amino acids. Is excellent,
It is suitable as a raw material for food.

【0024】本発明においては上記のようにして製造し
た乳酸菌発酵液を最終製品中の乾燥酵母含量が0.5〜
10.0重量%程度になるように希釈し、また必要に応
じて通常食品に用いられる甘味剤、果汁、野菜汁、酸味
剤、香味剤、着色剤、強化剤等の添加剤を加えて味を整
えた乳酸菌飲料を得ることができる。もちろん、発酵液
をそのまま乳酸発酵飲料としてもよい。
In the present invention, the lactic acid bacteria fermented liquor produced as described above has a dry yeast content in the final product of 0.5 to 0.5%.
Dilute to about 10.0% by weight, and add additives such as sweeteners, fruit juice, vegetable juice, sour agents, flavoring agents, coloring agents, and fortifying agents, which are usually used in foods, as needed. Can be obtained. Of course, the fermented liquid may be used directly as a lactic acid fermented beverage.

【0025】乳酸菌飲料は、乳を原料として用いない非
乳製品の乳酸菌飲料を主とするが、乳を原料の一部とし
て用いた乳酸菌飲料(生菌乳製品乳酸菌飲料、殺菌乳製
品乳酸菌飲料など)であってもよい。
The lactic acid bacteria drinks are mainly non-dairy lactic acid bacteria drinks that do not use milk as a raw material. However, lactic acid bacteria drinks using milk as a part of the raw material (such as live lactic acid lactic acid drinks and sterilized lactic acid lactic acid drinks) ).

【0026】その他の食品の形態については、本発明に
係る乳酸菌発酵液を、そのまま、或いは、濃縮,乾燥さ
せるなどして加工した後、任意の食品に配合することも
できる。例えば、粉末飲料、タブレット、カプセル、キ
ャンディー、ゼリー、ヨーグルト、チョコレート、揚げ
菓子、焼き菓子、パン、ケーキ類などの形状の食品に調
製することができる。これら食品においても、酵母の味
や酵母の臭みがマスキングされ、また、香味の点で優れ
ており、摂取しやすい。
With respect to other food forms, the fermented lactic acid bacterium of the present invention can be used as it is or after being processed by concentration, drying, etc., and then mixed with any food. For example, it can be prepared into foods in the form of powdered beverages, tablets, capsules, candy, jelly, yogurt, chocolate, fried confectionery, baked confectionery, bread, cakes and the like. Also in these foods, the taste of yeast and the smell of yeast are masked, and they are excellent in flavor and easy to ingest.

【0027】本明細書における「食品」には、乳酸菌飲
料、その他上記したような乳酸菌発酵液を原料として調
製された食品が含まれる。
The term "food" in the present specification includes lactic acid bacteria beverages and other foods prepared from the above-mentioned lactic acid bacteria fermented liquid.

【0028】本発明方法により得られた乳酸菌発酵液を
原料として調製された食品は、良質な蛋白、必須アミノ
酸をバランスよく含み、また、ビタミン、ミネラルなど
を豊富に含み、ビタミン補給、栄養強化などの作用が期
待できる。
The food prepared from the fermented lactic acid bacterium obtained by the method of the present invention contains good-quality proteins and essential amino acids in a well-balanced manner, is rich in vitamins and minerals, and is rich in vitamin supplementation and nutritional enhancement. Can be expected.

【0029】従って、本発明の食品は、食事が偏りがち
な人や食生活が不規則な人を対象とした健康食品、機能
性食品、特定保健用食品又は病者用食品という用途に用
いることができる。
Therefore, the food of the present invention can be used as a health food, a functional food, a food for specified health use, or a food for the sick, intended for people who tend to eat unevenly or who have an irregular diet. Can be.

【0030】また、本発明方法では乾燥酵母をそのまま
発酵しているため、細胞壁又はその一部が含まれる。細
胞壁の主成分はβ―グルカンであり、体内で食物繊維の
ような働きをすることが知られているので、乳酸菌と相
まって、整腸作用が発揮される。
Further, in the method of the present invention, since the dry yeast is fermented as it is, it contains the cell wall or a part thereof. Since the main component of the cell wall is β-glucan, which is known to function like dietary fiber in the body, it exerts intestinal action in combination with lactic acid bacteria.

【0031】具体的には、下記の実施例に示すように、
本発明方法により得られた乳酸菌発酵液を原料として調
製された食品は、排便回数、便の形状・硬さ(柔らか
さ)、便の容量、排便後の感覚(すっきり感)などの、
便通・便性を改善する効果を有している。さらに、便通
・便性を改善することにより、それに伴う肌荒れ、吹き
出物、腹部膨満感などを改善する作用も期待できる。
Specifically, as shown in the following examples,
The food prepared using the lactic acid bacteria fermented liquid obtained by the method of the present invention as a raw material includes the number of defecations, the shape and hardness of the stool (softness), the volume of the stool, the feeling after stool (clearness), and the like.
It has the effect of improving bowel movement and convenience. In addition, by improving bowel movement and stool, an effect of improving skin roughness, breakouts, abdominal bloating, and the like that accompanies it can be expected.

【0032】従って、本発明の食品は、整腸のための、
健康食品、機能性食品、特定保健用食品又は病者用食品
という用途に用いることができる。
Therefore, the food of the present invention is useful for
It can be used for applications such as health foods, functional foods, foods for specified health use, or foods for the sick.

【0033】また、本発明方法により得られた乳酸菌発
酵液を原料として調製された食品は、体内で食物繊維の
ような働きをするβ―グルカンを主成分とする細胞壁又
はその一部が含まれているので、乳酸菌と相まって、免
疫賦活作用や、免疫機能を整える作用が期待できる。
The food prepared from the fermented lactic acid bacterium obtained by the method of the present invention contains a cell wall mainly composed of β-glucan which functions as a dietary fiber in the body or a part thereof. Therefore, in combination with lactic acid bacteria, it can be expected to have an immunostimulating effect and an effect of regulating immune function.

【0034】従って、本発明の食品は、免疫強化のた
め、或いは免疫機能を整えるための、健康食品、機能性
食品、特定保健用食品又は病者用食品という用途に用い
ることができる。
Therefore, the food of the present invention can be used for applications such as health foods, functional foods, foods for specified health use, or foods for the sick, for enhancing immunity or for regulating the immune function.

【0035】乳酸菌発酵液は、食品原料以外にも、医薬
品原料、培地原料、動物薬の原料、飼料原料などの用途
にも用いることができる。
The fermented lactic acid bacterium can be used not only as a food material but also as a drug material, a culture medium material, an animal drug material, a feed material and the like.

【0036】例えば、上記乳酸菌飲料を原料とする医薬
は、整腸したり、便通・便性を改善する作用を有してい
るので、便秘薬、整腸薬、下剤(瀉下薬)として有用で
ある。
For example, pharmaceuticals made from the above-mentioned lactic acid bacteria drink are useful as constipation drugs, intestinal medicines, laxatives (laxatives), because they have the effect of regulating bowel movements and improving bowel movements and feces. is there.

【0037】かかる医薬組成物は、本発明の乳酸菌発酵
液を医薬品原料として、これを適当な無毒性の製剤学的
に許容される担体と共に用いて、一般的な医薬製剤の形
態として実用される。
Such a pharmaceutical composition is put into practical use as a general pharmaceutical preparation by using the fermented lactic acid bacterium of the present invention as a pharmaceutical raw material and using it together with a suitable non-toxic pharmaceutically acceptable carrier. .

【0038】上記医薬製剤の投与単位形態としては、各
種の形態が選択でき、その代表的なものとしては、錠
剤、丸剤、顆粒剤、カプセル剤等の固形製剤;内用散剤
等の粉体製剤;液剤、懸濁剤、乳剤、シロップ剤等の液
状製剤が挙げられる。
As the dosage unit form of the above pharmaceutical preparation, various forms can be selected, and typical examples are solid preparations such as tablets, pills, granules and capsules; powders such as powders for internal use Preparations: liquid preparations such as solutions, suspensions, emulsions, syrups and the like.

【0039】本発明医薬製剤に利用される上記製剤学的
に許容される担体としては、製剤の使用形態に応じて通
常使用される、結合剤、崩壊剤、界面活性剤、吸収促進
剤、吸着剤、滑沢剤、充填剤、増量剤、付湿剤等の希釈
剤又は賦形剤を例示できる。これらは得られる製剤の投
与単位形態に応じて適宜選択して使用される。
The above-mentioned pharmaceutically acceptable carriers used in the pharmaceutical preparation of the present invention include binders, disintegrants, surfactants, absorption promoters, and adsorbents which are usually used depending on the use form of the preparation. Examples include diluents or excipients such as agents, lubricants, fillers, extenders, and humectants. These are appropriately selected and used according to the dosage unit form of the obtained preparation.

【0040】更に、本発明医薬製剤には、必要に応じて
防腐剤、甘味剤、着色剤、抗酸化剤、保存剤、香料、風
味剤等や他の医薬品を含有させ、医薬製剤として調製す
ることもできる。
Further, the pharmaceutical preparation of the present invention may contain a preservative, a sweetening agent, a coloring agent, an antioxidant, a preservative, a flavor, a flavoring agent, and other pharmaceuticals, if necessary, to prepare a pharmaceutical preparation. You can also.

【0041】上記医薬製剤は、当該形態における常法に
従って調製することができる。また、上記医薬製剤は、
通常経口投与される。
The above pharmaceutical preparation can be prepared according to a conventional method in the above-mentioned form. In addition, the pharmaceutical preparation,
Usually administered orally.

【0042】本発明の食品又は医薬製剤の摂取量につい
ては、摂取の目的、食品又は医薬製剤の形態、摂取者の
年齢、性別その他の条件に応じて適宜選択されるが、通
常、乾燥酵母量として、1日成人1人当たり0.01〜
20g程度、好ましくは0.1〜10g程度となるよう
な量とするのがよく、1日に1回又は2〜4回に分けて
摂取することができる。
The amount of the food or pharmaceutical preparation of the present invention to be taken is appropriately selected depending on the purpose of ingestion, the form of the food or the pharmaceutical preparation, the age, sex, and other conditions of the ingestor. As per 0.01 adult per day
The dose is preferably about 20 g, preferably about 0.1 to 10 g, and can be taken once a day or divided into two to four times a day.

【0043】本発明食品又は医薬製剤は、その目的に応
じて摂取期間を設定することができる。
[0043] The food or pharmaceutical preparation of the present invention can have a period of intake depending on the purpose.

【0044】例えば、便秘の人が便秘の症状を改善する
ためには、症状が改善されるまで1日〜12週間程度、
好ましくは3日〜3週間程度連続的に摂取することが好
ましく、改善後も、1週間に1〜7日、好ましくは2〜
4日程度摂取して排便習慣を維持するのが望ましい。
For example, in order for a person with constipation to improve the symptoms of constipation, it takes about 1 day to 12 weeks until the symptoms are improved.
Preferably, it is preferably taken continuously for about 3 days to 3 weeks, and after improvement, 1 to 7 days a week, preferably 2 to 3 weeks.
It is desirable to maintain the bowel habit by ingesting for about 4 days.

【0045】便秘ぎみの人、便秘がちな人、便秘になり
やすい人、便秘傾向にある人などは、排便習慣を維持す
るために、1週間に1〜7日程度、好ましくは2〜4日
程度の割合で、本発明の食品又は医薬製剤を継続的に摂
取して、お腹の調子を整えたり便秘になりにくいように
することができる。
For a person with constipation, a person who tends to be constipated, a person who tends to be constipated, a person who tends to be constipated, etc., about 1 to 7 days, preferably 2 to 4 days a week to maintain the defecation habit. At a moderate rate, the food or pharmaceutical formulation of the present invention can be taken continuously to condition the stomach and make it less prone to constipation.

【0046】また、軟便の人が便の硬さを改善するため
には、便の硬さが改善されるまで、通常1日〜24週間
程度、好ましくは3日〜12週間程度連続的に摂取する
ことが好ましく、改善後も、1週間に1〜7日程度、好
ましくは2〜4日程度摂取して排便習慣を維持するのが
望ましい。
In order for a person with loose stool to improve the stool hardness, the stool is usually taken continuously for about 1 day to 24 weeks, preferably for about 3 days to 12 weeks, until the stool hardness is improved. It is preferable to maintain the bowel habit by ingesting about 1 to 7 days, preferably about 2 to 4 days a week after the improvement.

【0047】軟便ぎみの人、軟便がちな人、軟便になり
やすい人、軟便傾向にある人などは、軟便にならないよ
うに、1週間に1〜7日、好ましくは2〜4日程度の割
合で、本発明の食品又は医薬製剤を継続的に摂取するこ
とができる。
[0048] The proportion of loose stool to those who tend to loose stool, those who tend to loose stool, and those who tend to loose stool is 1 to 7 days per week, preferably 2 to 4 days. Thus, the food or pharmaceutical preparation of the present invention can be continuously taken.

【0048】[0048]

【実施例】以下、実施例及び比較例を挙げて本発明の効
果をさらに詳しく説明するが、本発明はこれらに限定さ
れるものではない。なお、「%」は特に断らない限り重量
%を意味する。
EXAMPLES Hereinafter, the effects of the present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto. "%" Means% by weight unless otherwise specified.

【0049】試験例1 種々の乳酸菌を用いて乾燥酵母の発酵試験を行った。Test Example 1 A fermentation test of dry yeast was performed using various lactic acid bacteria.

【0050】乾燥ビール酵母15%,グルコースを3%
添加した懸濁液を調整後、90℃,10分の殺菌を行
い、すみやかに冷却して乳酸菌発酵培地とした。これら
の培地に対して、あらかじめ培養しておいた9種の乳酸
菌スターターをそれぞれ1%接種し、37℃,28時間
静置発酵した。スターターは、発酵に用いる乳酸菌を、
酵母エキスを添加した12%還元脱脂乳からなる培地を
用いて、36℃で20時間培養して調製した。
Dry beer yeast 15%, glucose 3%
After adjusting the added suspension, the mixture was sterilized at 90 ° C. for 10 minutes, and immediately cooled to obtain a lactic acid bacteria fermentation medium. Each of these mediums was inoculated with 1% of each of 9 types of lactic acid bacteria starters that had been cultured in advance, and was fermented at 37 ° C. for 28 hours. The starter uses lactic acid bacteria used for fermentation,
It was prepared by culturing for 20 hours at 36 ° C. using a medium consisting of 12% reduced skim milk to which yeast extract was added.

【0051】発酵終了後の発酵液の乳酸酸度、および香
味評価結果を以下の表1に示す。なお香味評価は専門パ
ネラー6名の、1(好ましくない)から5(好ましい)
の5段階評価の合計点でスコア化した。
Table 1 below shows the lactic acidity of the fermented liquor after the fermentation and the results of flavor evaluation. In addition, the flavor evaluation was performed by 6 expert panelists, from 1 (unfavorable) to 5 (favorable).
Were scored based on the total score of the five-step evaluation.

【0052】[0052]

【表1】 [Table 1]

【0053】未発酵の比較例1は、酵母の味が強かった
が、乳酸菌発酵させた実施例1〜9は、比較例1と比べ
て酵母の味がほとんどなく、酵母の臭い及び味のマスキ
ング効果が示された。また、表1に示すごとく、ラクト
バチルス属の通性ヘテロ発酵タイプの菌(コリニフォル
ミス,アリメンタリウス,カゼイ,ラムノサス及びプラ
ンタラム)良好な酵母臭乃至酵母味のマスキング効果が
認められた。
The unfermented Comparative Example 1 had a strong yeast taste, while the lactic acid bacteria-fermented Examples 1 to 9 had little yeast taste compared to Comparative Example 1, and had a yeast odor and taste masking. The effect was shown. In addition, as shown in Table 1, a facultative heterofermentative bacterium of the genus Lactobacillus (Coriniformis, Alimentarius, Casei, Rhamnosus and Plantarum) showed a good yeast odor or yeast taste masking effect.

【0054】試験例2 発酵時の発酵糖質源の種類及び発酵条件について検討を
行った。
Test Example 2 The type of fermented carbohydrate source and the fermentation conditions during fermentation were examined.

【0055】試験例1の発酵糖質源を種々の糖質(固形
分換算で3%添加)に置き換えた培地を同様に調整し、
ラクトバチルス・ラムノサスをスターターとして37
℃,20時間、静置発酵(実施例10〜17),または
スターラーにて攪拌条件下(実施例18〜25)で発酵
を行った。発酵終了後の発酵液の乳酸酸度、および香味
評価結果を以下に示す。なお香味評価はさらに詳細に解
析を行うべく、5種の香味の項目(エグ味,苦味,ざら
つき,呈味,生臭さ)について、専門パネラー6名の1
(好ましくない)から5(好ましい)の5段階評価の合
計点でスコア化した。結果を表2及び表3に示す。
A medium in which the fermented carbohydrate source of Test Example 1 was replaced with various carbohydrates (3% added in terms of solid content) was similarly prepared,
Starting with Lactobacillus rhamnosus 37
Fermentation was carried out at 20 ° C. for 20 hours under static fermentation (Examples 10 to 17) or with a stirrer under stirring conditions (Examples 18 to 25). The lactic acidity of the fermented liquor after completion of the fermentation and the results of flavor evaluation are shown below. In order to analyze the flavor in more detail, one of six expert panelists evaluated the five flavor items (egg taste, bitterness, roughness, taste, and fresh odor).
Scores were given on a total of 5 (unfavorable) to 5 (preferred) evaluations. The results are shown in Tables 2 and 3.

【0056】[0056]

【表2】 [Table 2]

【0057】[0057]

【表3】 [Table 3]

【0058】表2,表3に示すごとく、全般的に良好な
香味の発酵液が得られたが、発酵糖質源に麦芽エキスを
用いること、および攪拌発酵を行うことによりさらに高
い香味改善が確認された。
As shown in Tables 2 and 3, fermented liquor having good flavor was obtained in general, but higher flavor was improved by using malt extract as a fermentation sugar source and stirring fermentation. confirmed.

【0059】実施例26 実施例25で得た乾燥酵母の乳酸菌発酵液を用い、下記
の処方により各成分を混合して、常法により乳酸菌飲料
を作成した。
Example 26 Using the fermented solution of lactic acid bacteria of dried yeast obtained in Example 25, each component was mixed according to the following formulation, and a lactic acid bacteria beverage was prepared by a conventional method.

【0060】試験例3 実施例26で得た飲料A、飲料Aの乳酸菌発酵液を実施
例17で得られた発酵液に置き換えた飲料B(実施例2
7)、実施例10で得られた発酵液に置き換えた飲料C
(実施例28)、比較例2の乳酸菌未発酵液に置き換え
た飲料C(比較例3)を用い、一般消費者50名(男性
25名,女性25名:平均年齢36歳)を対象として官
能評価を行った。結果を表4に示す。
Test Example 3 Beverage A obtained in Example 26 and Beverage B obtained by replacing the fermented solution of lactic acid bacteria of drink A with the fermented solution obtained in Example 17 (Example 2)
7) Beverage C replaced with fermented liquid obtained in Example 10
(Example 28), using beverage C (Comparative Example 3) replaced with the unfermented lactic acid bacterium solution of Comparative Example 2, sensory for 50 general consumers (25 males, 25 females: average age 36 years) An evaluation was performed. Table 4 shows the results.

【0061】[0061]

【表4】 [Table 4]

【0062】表4の結果から判るように、通常香味に劣
る乾燥酵母を、乳酸菌、特にラクトバチルス属の通性ヘ
テロタイプの乳酸菌で発酵することにより、酵母のもつ
不快臭,不快味をマスキングし、飛躍的に嗜好性に優れ
た酵母含有飲料を得ることができ、さらには発酵等質源
に麦芽エキスを用いる,または好気(攪拌)条件にて発
酵することによりそのマスキング効果を向上できること
が明らかである。
As can be seen from the results shown in Table 4, the unpleasant odor and unpleasant taste of the yeast are masked by fermenting the dry yeast, which is usually inferior in flavor, with a lactic acid bacterium, particularly a lactobacillus facultative heterotype lactic acid bacterium. In addition, it is possible to obtain a yeast-containing beverage having a remarkably excellent palatability, and it is possible to improve its masking effect by using malt extract as a fermentation homogenous source or by fermenting under aerobic (stirring) conditions. it is obvious.

【0063】試験例4 便秘症状を自覚する成人を対象として、乾燥ビール酵母
錠剤及び乾燥ビール酵母の乳酸菌発酵液を原料とする飲
料による、排便(便通・便性)に及ぼす影響について検
討した。
Test Example 4 The effects of dried brewer's yeast tablets and a beverage made from a fermented solution of lactic acid bacteria on dried brewer's yeast on defecation (constipation and stool) were examined for adults who were conscious of constipation symptoms.

【0064】乾燥ビール酵母錠剤としては、乾燥ビール
酵母を錠剤の製造に慣用されている担体を用いて錠剤の
形態として得られたものを用いた。乳酸菌発酵ビール酵
母飲料としては、前記乾燥ビール酵母を乳酸菌(Lactob
acillus rhamnosus)で発酵して得られた乳酸菌発酵液
を配合して加熱殺菌して得られた飲料を用いた。
As the dried brewer's yeast tablet, a brewer's yeast obtained in the form of a tablet using a carrier commonly used for tablet production was used. As the lactic acid bacteria fermented beer yeast beverage, the dried beer yeast is used as a lactic acid bacteria ( Lactob
acillus rhamnosus ), and a beverage obtained by blending a lactic acid bacteria fermented solution obtained by fermentation and heat sterilization was used.

【0065】9名のボランティアに乾燥ビール酵母錠剤
を1日25錠(乾燥酵母量として3.75g)<以下、
“錠剤群”とする>、8名に乳酸菌発酵ビール酵母飲料
を1日1缶(160g、乾燥酵母量として3.75g)
<以下、“飲料群”とする>、それぞれ3週間摂取させ
た。錠剤群には、摂取時に飲料とほぼ同量の水も摂取さ
せた。摂取期間の前に2週間の非摂取期間を設け、排便
に関するアンケート調査を実施した。排便量はφ25m
m×85mmの円柱本数に見たてて記入させた(1:1
本未満、2:2本未満、3:3本未満、4:4本未満、
5:4本以上)。排便後の感覚は、1:すっきり、2:
普通、3:すっきりしない、という基準により記入させ
た。試験期間中、乳酸菌製剤、乳酸菌飲料、食物繊維、
オリゴ糖配合飲料、糖アルコール強化飲料・食品、野菜
ジュース、医薬品(抗生物質、整腸剤、下剤)など便通
・便性に影響を与える可能性がある食品や薬剤の摂取を
控えさせた以外は特に食事制限を行わなかった。摂取前
2週間のうち1週目は調整期間とし、摂取前2週目を対
照期間として設定した。
Nine volunteers received 25 dried beer yeast tablets daily (3.75 g as dry yeast amount).
The “tablet group”>, 8 cans of lactic acid bacteria fermented beer yeast drink per day (160 g, 3.75 g as dry yeast amount) for 8 persons
<Hereinafter referred to as “drink group”>, each of which was ingested for 3 weeks. The tablet group also received approximately the same amount of water as the beverage at the time of ingestion. A two-week non-ingestion period was provided before the ingestion period, and a questionnaire survey on defecation was conducted. Defecation volume is φ25m
It was made to fill in by looking at the number of cylinders of mx 85 mm (1: 1
Less than 2, less than 2: 3, less than 3: 3, less than 4: 4,
5: 4 or more). The feeling after defecation is 1: clean, 2:
Ordinary 3: Filled out according to the criteria of not clear. During the test period, lactic acid bacteria preparations, lactic acid bacteria drinks, dietary fiber,
Meals except for those who have refrained from taking foods or drugs that may affect bowel movement or stool, such as oligosaccharide-containing beverages, sugar alcohol-enriched beverages and foods, vegetable juices, and pharmaceuticals (antibiotics, intestinal preparations, laxatives) No restrictions were made. The first week of the two weeks before ingestion was set as an adjustment period, and the second week before ingestion was set as a control period.

【0066】各群について統計学的検定を行った結果、
飲料群について、摂取期間中に排便回数、容量、排便後
の感覚(すっきり感)に有意な改善が認められた。錠剤
群に関しては、摂取により便通改善の傾向は見られた
が、有意な差ではなかった。また、飲み易さに関して
は、錠剤群は錠剤を25錠毎日飲むのが困難であるボラ
ンティアもいたが、飲料群は1日摂取量が160gであ
り、臭みや苦みなどが抑えられているので毎日飲用する
のは特に大変ではなかった。
As a result of performing a statistical test on each group,
For the beverage group, significant improvements were observed in the number of defecations, volume, and feeling (clearness) after defecation during the ingestion period. In the tablet group, there was a tendency to improve bowel movement by ingestion, but this was not a significant difference. In addition, regarding the ease of drinking, there were some volunteers who had difficulty taking 25 tablets daily in the tablet group, but the drink group had a daily intake of 160 g, and odors and bitterness were suppressed. Drinking was not particularly difficult.

【0067】試験例5 軟便の成人を対象として、試験例4と同一の,乾燥ビー
ル酵母の乳酸菌発酵液を原料とする飲料が、便性に及ぼ
す影響について検討した。
Test Example 5 The effects of the same beverage as a raw material containing a fermented solution of dried brewer's yeast on lactic acid bacteria, as in Test Example 4, were examined for stool in adults with loose stool.

【0068】7名のボランティアに乳酸菌発酵ビール酵
母飲料を1日1缶(160g、乾燥酵母量として3.7
5g)を3ヶ月間摂取させた。摂取期間の前に2週間非
摂取期間を設け、便性に関するアンケート調査を実施し
た。便の形状及び硬さについて下記の評価に従って記録
させた。 便の形状:1.水状 2.泥状 3.半練り状 4.バ
ナナ状 5.カチカチ状6.コロコロ状 便の硬さ:1.非常に柔らかい 2.軟らかい 3.ふ
つう 4.硬い 5.非常に硬い 結果を表5に示す。
One liter of fermented lactic acid bacteria beer yeast drink per day (160 g, 3.7 dry yeast amount) was given to 7 volunteers.
5 g) for 3 months. A two-week non-ingestion period was provided before the ingestion period, and a questionnaire survey was conducted on convenience. The shape and hardness of the stool were recorded according to the following evaluation. Stool shape: 1. Watery 2. Muddy 3. 3. Semi-mixed Banana shape 5. 5. Tick Rolled stool hardness: 1. Very soft 2. Soft 3 Usually 4. Hard 5. Very hard results are shown in Table 5.

【0069】[0069]

【表5】 [Table 5]

【0070】統計学的検定を行った結果、摂取期間中に
便の形状及び硬さについて、保形性が改善される方向で
有意差が認められた。
As a result of a statistical test, a significant difference was observed in the shape and hardness of the stool during the ingestion period in the direction of improving the shape retention.

【0071】以上の結果より、本発明の乳酸菌発酵ビー
ル酵母飲料は、便通乃至便性の改善に有用であることが
明らかになった。
From the above results, it has been clarified that the lactic acid bacteria-fermented beer yeast beverage of the present invention is useful for improving bowel movement and stool.

【0072】[0072]

【発明の効果】本発明によれば、栄養学的価値が高いが
加工食品として摂取し難い乾燥酵母を、乳酸菌発酵する
ことにより、嗜好性に優れた乳酸菌飲料などの乳酸菌発
酵液を原料とする食品や医薬製剤が提供される。また、
本発明の乳酸菌発酵液を原料とする食品や医薬製剤によ
れば、整腸作用が得られ、便通・便性が改善する。
According to the present invention, lactic acid bacteria fermentation of dry yeast having high nutritional value but difficult to ingest as processed food is used as a raw material for lactic acid bacteria fermented liquids such as lactic acid bacteria beverages having excellent palatability. Food and pharmaceutical preparations are provided. Also,
ADVANTAGE OF THE INVENTION According to the foodstuff or pharmaceutical preparation which uses the fermented lactic acid bacterium solution of the present invention as a raw material, an intestinal regulation action is obtained, and bowel movement and stool are improved.

【図面の簡単な説明】[Brief description of the drawings]

【図1】乳酸菌発酵ビール酵母飲料による排便回数の変
化を示す図。
FIG. 1 is a diagram showing a change in the number of defecations by a lactic acid bacteria fermented beer yeast beverage.

【図2】酵母錠剤摂取による排便回数の変化を示す図。FIG. 2 is a diagram showing a change in the number of bowel movements due to yeast tablet ingestion.

【図3】乳酸菌発酵ビール酵母飲料による排便容量の変
化を示す図。
FIG. 3 is a diagram showing a change in defecation volume due to a lactic acid bacteria fermented beer yeast beverage.

【図4】酵母錠剤摂取による排便容量の変化を示す図。FIG. 4 is a diagram showing a change in defecation volume due to yeast tablet ingestion.

【図5】乳酸菌発酵ビール酵母飲料による排便後の感覚
(すっきり感)の変化を示す図。
FIG. 5 is a diagram showing changes in sensation (clearness) after defecation by a lactic acid bacteria-fermented beer yeast beverage.

【図6】酵母錠剤摂取による排便後の感覚(すっきり
感)の変化を示す図。
FIG. 6 is a graph showing changes in sensation (clearness) after defecation due to ingestion of yeast tablets.

フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 1/14 A61P 1/14 C12N 1/20 C12N 1/20 A // A23C 9/127 A23C 9/127 (C12N 1/20 (C12N 1/20 A C12R 1:225) C12R 1:225) (C12N 1/20 (C12N 1/20 A C12R 1:25) C12R 1:25) Fターム(参考) 4B001 AC31 AC32 AC99 BC14 EC05 4B018 LE05 MD81 MD86 ME03 ME11 MF13 4B065 AA30X AA80X BB22 BB26 BC05 BC08 CA42 CA44 4C087 AA01 AA02 AA03 BC11 BC56 CA10 NA14 ZA72 ZA73 Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (reference) A61P 1/14 A61P 1/14 C12N 1/20 C12N 1/20 A // A23C 9/127 A23C 9/127 (C12N 1 / 20 (C12N 1/20 A C12R 1: 225) C12R 1: 225) (C12N 1/20 (C12N 1/20 A C12R 1:25) C12R 1:25) F term (reference) 4B001 AC31 AC32 AC99 BC14 EC05 4B018 LE05 MD81 MD86 ME03 ME11 MF13 4B065 AA30X AA80X BB22 BB26 BC05 BC08 CA42 CA44 4C087 AA01 AA02 AA03 BC11 BC56 CA10 NA14 ZA72 ZA73

Claims (9)

【特許請求の範囲】[Claims] 【請求項1】乾燥酵母を乳酸菌で発酵することを特徴と
する、乳酸菌発酵液の製造方法。
1. A method for producing a lactic acid bacteria fermented liquid, comprising fermenting dried yeast with lactic acid bacteria.
【請求項2】発酵を、好気的条件で行うことを特徴とす
る請求項1記載の製造方法。
2. The method according to claim 1, wherein the fermentation is performed under aerobic conditions.
【請求項3】発酵を、麦芽エキスの存在下で行うことを
特徴する請求項1または2記載の製造方法。
3. The method according to claim 1, wherein the fermentation is performed in the presence of a malt extract.
【請求項4】乳酸菌としてLactobacillus rhamnosus
Lactobacillus plantarumからなる群より選ばれる少
なくとも1種を用いることを特徴とする請求項1〜3の
いずれかに記載の製造方法。
4. The method according to claim 1, wherein the lactic acid bacterium is at least one selected from the group consisting of Lactobacillus rhamnosus and Lactobacillus plantarum .
【請求項5】乾燥酵母が、乾燥ビール酵母であることを
特徴とする請求項1〜4のいずれかに記載の製造方法。
5. The method according to claim 1, wherein the dried yeast is a dried brewer's yeast.
【請求項6】乾燥酵母を乳酸菌で発酵して得ることがで
きる乳酸菌発酵液を原料とする食品。
6. A food product comprising a fermented solution of lactic acid bacteria, which can be obtained by fermenting dry yeast with lactic acid bacteria.
【請求項7】整腸作用を有する、請求項6に記載の食
品。
7. The food according to claim 6, which has an intestinal action.
【請求項8】乾燥酵母を乳酸菌で発酵して得ることがで
きる乳酸菌発酵液を原料として含む便秘薬。
8. A constipation drug containing as a raw material a lactic acid bacteria fermented liquid obtained by fermenting dry yeast with lactic acid bacteria.
【請求項9】乾燥酵母を乳酸菌で発酵して得ることがで
きる乳酸菌発酵液を原料として含む整腸薬。
9. An intestinal medicine containing, as a raw material, a fermented lactic acid bacterium obtained by fermenting dry yeast with lactic acid bacteria.
JP2001190333A 2000-12-15 2001-06-22 Method for producing lactic acid bacteria fermentation broth and food made from the fermentation broth Expired - Fee Related JP4336930B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001190333A JP4336930B2 (en) 2000-12-15 2001-06-22 Method for producing lactic acid bacteria fermentation broth and food made from the fermentation broth

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000382480 2000-12-15
JP2000-382480 2000-12-15
JP2001190333A JP4336930B2 (en) 2000-12-15 2001-06-22 Method for producing lactic acid bacteria fermentation broth and food made from the fermentation broth

Publications (2)

Publication Number Publication Date
JP2002238494A true JP2002238494A (en) 2002-08-27
JP4336930B2 JP4336930B2 (en) 2009-09-30

Family

ID=26605940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001190333A Expired - Fee Related JP4336930B2 (en) 2000-12-15 2001-06-22 Method for producing lactic acid bacteria fermentation broth and food made from the fermentation broth

Country Status (1)

Country Link
JP (1) JP4336930B2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062385A1 (en) * 2003-01-10 2004-07-29 Mitsui Sugar Co., Ltd. Fermented soybean milk containing palatinose
WO2004078188A1 (en) * 2003-03-07 2004-09-16 Aureo Co., Ltd. COMPOSITION CONTAINING β-GLUCAN AND CONSTIPATION-RELIEVING DRUG, IMMUNOPOTENTIATOR AND SKIN MOISTENING AGENT USING THE COMPOSITION
JP2004269408A (en) * 2003-03-07 2004-09-30 Aureo Co Ltd Humectant for skin
JP2004269407A (en) * 2003-03-07 2004-09-30 Aureo Co Ltd Constipation ameliorant and food and beverage containing the same
JP2011101636A (en) * 2009-10-13 2011-05-26 Sanei Gen Ffi Inc Method for masking unpleasant taste which collagen has
JP2012188453A (en) * 2004-12-24 2012-10-04 Meiji Co Ltd Skin improver and method for improving skin
WO2013146201A1 (en) * 2012-03-28 2013-10-03 サッポロビール株式会社 Solution containing components of starting plant material, beverage, and method relating thereto
WO2014118190A1 (en) * 2013-01-29 2014-08-07 Erdinger Weissbräu Franz Brombach e.K. Method for producing an acid malt, an acid malt, method for producing a mash or wort, mash or wort, method for producing a drink, a drink, method for producing a concentrate, a concentrate
WO2014118191A1 (en) * 2013-01-29 2014-08-07 Erdinger Weissbräu Franz Brombach e.K. Method for producing a foodstuff and the thus produced foodstuff and use of lactic acid bacteria, acid malt, a mash, a wort, a drink or a concentrate
JP2016002001A (en) * 2014-06-13 2016-01-12 テーブルマーク株式会社 Degradation inhibitor
KR102063248B1 (en) * 2019-02-18 2020-01-07 이상복 Powdered yogurt and its manufacturing method

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062385A1 (en) * 2003-01-10 2004-07-29 Mitsui Sugar Co., Ltd. Fermented soybean milk containing palatinose
WO2004078188A1 (en) * 2003-03-07 2004-09-16 Aureo Co., Ltd. COMPOSITION CONTAINING β-GLUCAN AND CONSTIPATION-RELIEVING DRUG, IMMUNOPOTENTIATOR AND SKIN MOISTENING AGENT USING THE COMPOSITION
JP2004269408A (en) * 2003-03-07 2004-09-30 Aureo Co Ltd Humectant for skin
JP2004269407A (en) * 2003-03-07 2004-09-30 Aureo Co Ltd Constipation ameliorant and food and beverage containing the same
JP2012188453A (en) * 2004-12-24 2012-10-04 Meiji Co Ltd Skin improver and method for improving skin
JP2011101636A (en) * 2009-10-13 2011-05-26 Sanei Gen Ffi Inc Method for masking unpleasant taste which collagen has
WO2013146201A1 (en) * 2012-03-28 2013-10-03 サッポロビール株式会社 Solution containing components of starting plant material, beverage, and method relating thereto
WO2014118190A1 (en) * 2013-01-29 2014-08-07 Erdinger Weissbräu Franz Brombach e.K. Method for producing an acid malt, an acid malt, method for producing a mash or wort, mash or wort, method for producing a drink, a drink, method for producing a concentrate, a concentrate
WO2014118191A1 (en) * 2013-01-29 2014-08-07 Erdinger Weissbräu Franz Brombach e.K. Method for producing a foodstuff and the thus produced foodstuff and use of lactic acid bacteria, acid malt, a mash, a wort, a drink or a concentrate
JP2016002001A (en) * 2014-06-13 2016-01-12 テーブルマーク株式会社 Degradation inhibitor
KR102063248B1 (en) * 2019-02-18 2020-01-07 이상복 Powdered yogurt and its manufacturing method

Also Published As

Publication number Publication date
JP4336930B2 (en) 2009-09-30

Similar Documents

Publication Publication Date Title
Buttriss Nutritional properties of fermented milk products
EP2177110B1 (en) Immunostimulating composition containing lactic acid bacteria
CN103653170B (en) Stachyose probiotics solid beverage
WO2019112054A1 (en) Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria
CN100345497C (en) Yoghurt and rice wine composite milk and its manufacturing method
CN103988863B (en) A low calorie and high nutrition baked food with health promotion function
CN102578228B (en) Sugar-free grain yoghurt
CN101396046A (en) Probiotics yoghourt and manufacture method and use thereof
KR101340277B1 (en) Fermented Rice Product Fermented by Lactic Acid Bacteria
TW200804591A (en) Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation
JP4336930B2 (en) Method for producing lactic acid bacteria fermentation broth and food made from the fermentation broth
WO2021149663A1 (en) Composition
KR101884634B1 (en) Lactobacillus fermented drink mixture having weight control effect
WO2019112053A1 (en) Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria
JP5603036B2 (en) Probiotic growth promoter
JP2005312424A (en) Method for producing fermented product using kefir grain, and fermented product obtained by the same
EP2210609B1 (en) Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin
KR101421284B1 (en) Composition for Improving Constipation and Manufacturing Method thereof
WO2019188943A1 (en) Composition for preventing and/or ameliorating decrease in brain blood flow
JP2010209015A (en) Composition for anti-allergy, and anti-allergic agent and anti-allergic food containing the same
JP2019097544A (en) Novel bacteria belonging to bifidobacterium and compositions comprising the same
KR102538090B1 (en) Food composition and health functional food containing Lactobacillus casei IDCC 3451 with proteolytic ability
KR102523775B1 (en) Food composition and health functional food containing Lactobacillus plantarum IDCC 3501 with proteolytic ability
JP7474596B2 (en) Novel Bifidobacterium bacteria, compositions containing said bacteria, and compositions for promoting the growth of said bacteria
JP7309436B2 (en) A composition for preventing or improving renal dysfunction, and pharmaceutical compositions and food and drink compositions using the composition for preventing or improving renal dysfunction

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080520

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090311

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090424

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090424

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090527

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090616

R150 Certificate of patent or registration of utility model

Ref document number: 4336930

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120710

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120710

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130710

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees